Mercy Medical Group St. Louis, Missouri, United States
Explore the link between type 2 diabetes (T2D) and cardiometabolic comorbidities, such as cardiovascular disease (CVD), emphasizing the need for a more comprehensive approach to T2D management. Highlight the importance of managing cardiovascular risk in adults with T2D who have or are at high risk for CVD. Review key findings from two cardiovascular outcomes trials (CVOT) across two GLP-1 RA treatment options. Dosing and administration information will also be discussed.
